ATE513551T1 - Zusammensetzungen und verfahren zur wiederherstellung der bakterienflora - Google Patents
Zusammensetzungen und verfahren zur wiederherstellung der bakterienfloraInfo
- Publication number
- ATE513551T1 ATE513551T1 AT04704822T AT04704822T ATE513551T1 AT E513551 T1 ATE513551 T1 AT E513551T1 AT 04704822 T AT04704822 T AT 04704822T AT 04704822 T AT04704822 T AT 04704822T AT E513551 T1 ATE513551 T1 AT E513551T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- bacterial flora
- subject
- restoring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44223803P | 2003-01-24 | 2003-01-24 | |
PCT/US2004/001775 WO2004067013A1 (en) | 2003-01-24 | 2004-01-23 | Compositions and methods for restoring bacterial flora |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE513551T1 true ATE513551T1 (de) | 2011-07-15 |
Family
ID=32825190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04704822T ATE513551T1 (de) | 2003-01-24 | 2004-01-23 | Zusammensetzungen und verfahren zur wiederherstellung der bakterienflora |
Country Status (4)
Country | Link |
---|---|
US (2) | US20040265291A1 (de) |
EP (1) | EP1596872B1 (de) |
AT (1) | ATE513551T1 (de) |
WO (1) | WO2004067013A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7029702B2 (en) | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
GB0505229D0 (en) * | 2005-03-15 | 2005-04-20 | Novexin Ltd | Methods for stabilising, protecting, solubilising and folding proteins |
DE102004025869A1 (de) * | 2004-05-27 | 2005-12-22 | Süd-Chemie AG | Bioprotektivum |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
US20080126195A1 (en) | 2004-07-22 | 2008-05-29 | Ritter Andrew J | Methods and Compositions for Treating Lactose Intolerance |
WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
US7955418B2 (en) | 2005-09-12 | 2011-06-07 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same |
EP2324838A1 (de) | 2005-09-12 | 2011-05-25 | Abela Pharmaceuticals, Inc. | Zusammensetzungen mit Dimethyl-Sulfoxid |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
EP1776877A1 (de) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Methode zur Förderung der Darmflora |
RU2445361C2 (ru) * | 2006-06-13 | 2012-03-20 | Нестек С.А. | Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий |
AU2008201950A1 (en) * | 2007-05-02 | 2008-11-20 | Sociedad De Biotecnologias Antofagasta Limitada | Kit and method to perform a biological test designed to evaluate minerals potential for being bioleached |
WO2009092810A2 (en) * | 2008-01-24 | 2009-07-30 | Bacterfield Oü | Single pharmaceutical composition containing antibiotics and probiotics |
WO2010036876A2 (en) * | 2008-09-25 | 2010-04-01 | New York University | Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
CA2984935C (en) | 2009-02-24 | 2021-01-12 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
CN102834520B (zh) | 2009-10-30 | 2016-05-25 | 生物基因创新有限责任公司 | 甲基磺酰甲烷(msm)用于调制微生物活性的用途 |
US9855212B2 (en) | 2009-10-30 | 2018-01-02 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases |
PL3564357T3 (pl) | 2010-02-01 | 2022-08-08 | Rebiotix, Inc. | Bakterioterapia zapalenia jelita grubego z clostridium difficile |
EP3202406A1 (de) | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Präbiotische formulierungen und deren verwendungen |
US8951512B2 (en) | 2010-05-04 | 2015-02-10 | New York University | Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota |
WO2012024638A2 (en) | 2010-08-20 | 2012-02-23 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
US20130280225A1 (en) * | 2010-12-29 | 2013-10-24 | Nestec S.A. | Fiber and probiotics for reducing intestinal symptoms related to stress |
SG191420A1 (en) * | 2010-12-29 | 2013-07-31 | Nestec Sa | Fiber and probiotics for reducing intestinal symptoms related to chronic stress |
US20150079039A1 (en) | 2012-04-13 | 2015-03-19 | The Regents Of The University Of California | Sinusitis diagnostics and treatments |
US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
EP4234011A3 (de) | 2013-06-05 | 2023-09-20 | Rebiotix, Inc. | Mikrobiotawiederherstellungstherapie (mrt), zusammensetzungen und verfahren zur herstellung |
US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
KR101677516B1 (ko) * | 2014-10-14 | 2016-11-18 | 대한민국 | 락토바실러스 루테리 블랙8, 및 이를 함유하는 항종양 조성물 |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
CA2986915C (en) | 2015-06-09 | 2023-09-19 | Rebiotix, Inc. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10653728B2 (en) | 2016-10-17 | 2020-05-19 | New York University | Probiotic compositions for improving metabolism and immunity |
CN107373036A (zh) * | 2017-09-04 | 2017-11-24 | 紫金县绿羽农业发展有限公司 | 一种复合微生态饲料添加剂的制备及应用 |
KR102268128B1 (ko) * | 2021-02-09 | 2021-06-22 | 주식회사 락토메이슨 | 모유 유래 신규한 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 월경전 증후군 완화용 조성물 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3689640A (en) * | 1967-09-28 | 1972-09-05 | Univ Of Nebraska The | Antibiotic acidophilin and process of preparing the same |
US3852454A (en) * | 1973-06-15 | 1974-12-03 | Merck & Co Inc | Treatment of rheumatoid arthritis |
US3897307A (en) * | 1974-10-23 | 1975-07-29 | Hansens Lab Inc | Stabilized dry cultures of lactic acid-producing bacteria |
GB2122892B (en) * | 1982-07-02 | 1986-01-29 | Squibb & Sons Inc | Nystantin pastille formulation |
US4592748A (en) * | 1984-05-18 | 1986-06-03 | Vortex Research Corp. | Yoghurt based douche kit and assembly therefor |
JPS6314665A (ja) * | 1986-07-07 | 1988-01-21 | Zenkoku Nogyo Kyodo Kumiai Rengokai | 繁殖雌豚飼育用飼料及びそれを用いて繁殖雌豚を飼育する方法 |
JP2806522B2 (ja) * | 1987-09-04 | 1998-09-30 | 日本食品化工株式会社 | 分岐フラクトオリゴ糖の製造方法 |
US4986985A (en) * | 1987-11-02 | 1991-01-22 | Bar Ilan University | Method of treating skin virus infections |
US5236697A (en) * | 1990-10-18 | 1993-08-17 | Schrauzer Gerhard N | Product for treatment of acne and other skin conditions |
US5518740A (en) * | 1990-12-13 | 1996-05-21 | Innovative Freeze-Drying Products (Ifdp) N.V. | Process for the preparation of yogurt based freeze-dried foodstuffs having a solid shape, and products obtained by said process |
US5792451A (en) * | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
US5580579A (en) * | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
IE80468B1 (en) * | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
WO1997029763A1 (en) * | 1996-02-14 | 1997-08-21 | The Procter & Gamble Company | Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
WO1998018610A1 (en) * | 1996-10-28 | 1998-05-07 | Lengerich Bernhard H Van | Embedding and encapsulation of controlled release particles |
US5837254A (en) * | 1996-11-14 | 1998-11-17 | Chen; Yu | Method of treating candida and cryptococcus fungal infections by administering gentian |
US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
JPH10330267A (ja) * | 1997-05-28 | 1998-12-15 | Meiji Seika Kaisha Ltd | ベロ毒素中和剤 |
US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
WO2001013956A2 (en) * | 1999-08-26 | 2001-03-01 | Ganeden Biotech, Inc. | Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
GB2369777B (en) * | 2000-10-05 | 2004-10-27 | St Ivel Ltd | Food products with antimicrobial lactic acid bacteria |
-
2004
- 2004-01-23 WO PCT/US2004/001775 patent/WO2004067013A1/en active Application Filing
- 2004-01-23 EP EP04704822A patent/EP1596872B1/de not_active Expired - Lifetime
- 2004-01-23 US US10/763,570 patent/US20040265291A1/en not_active Abandoned
- 2004-01-23 AT AT04704822T patent/ATE513551T1/de not_active IP Right Cessation
-
2009
- 2009-09-22 US US12/564,813 patent/US20100189702A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1596872A1 (de) | 2005-11-23 |
US20040265291A1 (en) | 2004-12-30 |
EP1596872B1 (de) | 2011-06-22 |
WO2004067013A1 (en) | 2004-08-12 |
US20100189702A1 (en) | 2010-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE513551T1 (de) | Zusammensetzungen und verfahren zur wiederherstellung der bakterienflora | |
IN2014DN06610A (de) | ||
ATE499091T1 (de) | Antimikrobielle materialien | |
WO2007130655A3 (en) | Phage derived antimicrobial activities | |
DE602005012276D1 (de) | Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut | |
BR112013005426A2 (pt) | "composto, composição, formulação farmacêutica, métodos para inibir uma enzima, para matar e/ou prevenir o crescimento de um micro-organismo, para tratar e/ou prevenir uma doença em um animal, e para inibir o domínio de edição de uma sintetase de t-rna, e, uso de um composto ou uma de combinação." | |
DE60216614D1 (de) | Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln | |
TW200734344A (en) | Antibacterial agents | |
TW200744639A (en) | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents | |
CR20230138A (es) | Identificación de composiciones microbianas beneficiosas para la agricultura y usos de estas | |
WO2013102021A3 (en) | LOW pH DISINFECTANT COMPOSITION | |
IL299036A (en) | Bacteria, microbial compounds and agriculturally beneficial associations | |
DE602004010540D1 (de) | Stabile zusammensetzungen von sporen, bakterien und/oder pilzen | |
MXPA05009352A (es) | Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
EP1917355A4 (de) | Ply-gbs-lysinmutanten | |
TW200716162A (en) | Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria | |
WO2009102143A3 (ko) | 김치유래 락토바실러스 플란타룸 bls41 및 그 용도 | |
PH12015502375A1 (en) | Antimicrobial compounds and methods of making and using the same | |
MX2023003089A (es) | Formas farmaceuticas solidas de bacterias. | |
EP3939599A3 (de) | Silikathaltige zusammensetzungen und verfahren zur behandlung | |
WO2006101486A3 (en) | Bacteriocins and novel bacterial strains | |
ZA202103181B (en) | Reduction of pathogenic bacteria using arginine | |
WO2012085255A3 (en) | Volatile organic compounds from bacterial antagonists for controlling microbial growth | |
MX2009006808A (es) | Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |